(Q43691642)

25 November 2017

title

Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway (English)

1 reference

25 November 2017

Jain NK

1

1 reference

25 November 2017

Patil CS

series ordinal

2

1 reference

25 November 2017

Singh A

series ordinal

3

1 reference

25 November 2017

Kulkarni SK

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

25 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

25 November 2017

volume

909

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

170-178

1 reference

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Sildenafil, a novel effective oral therapy for male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Effect of topical administration of l‐arginine on formalin‐induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Sildenafil produces antinociception and increases morphine antinociception in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Inducible nitric oxide synthase: what difference does it make?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

7 January 2021

cGMP signal termination

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902673-7

10.1016/S0006-8993(01)02673-7

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference